Fenestrated Atrial Septal Defect Percutaneously Occluded by a Single Device: Procedural and Financial Considerations

Tal, Roie; Qarawani, Dahud; Lorber, Avraham

doi:10.1007/s40119-012-0009-5

Cited by 10 publications

(13 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 In this way, we usually can close all defects with a single device and often in some cases, a small residual defect is left behind with hemodynamically nonsignificant shunt. 12 …”

Section: Discussionmentioning

confidence: 99%

Atrial septal defect device closure and concurrent atrio‐fascicular Mahaim ablation in adult patient with Ebstein's anomaly

Khajali

Firouzi

Kabir³

et al. 2022

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…11 In this way, we usually can close all defects with a single device and often in some cases, a small residual defect is left behind with hemodynamically nonsignificant shunt. 12 …”

Section: Discussionmentioning

confidence: 99%

Atrial septal defect device closure and concurrent atrio‐fascicular Mahaim ablation in adult patient with Ebstein's anomaly

Khajali

Firouzi

Kabir³

et al. 2022

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…[ 15 ] In many such cases, all the defects get closed with a single oversized device or in some, a small residual defect with hemodynamically insignificant shunt is left behind. [ 15 16 ] However, this strategy is unlikely to work if there are multiple satellite defects which are farther than 7 mm from the main defect resulting in a significant residual shunting. Some authors have also performed a central puncture in the IAS to successfully close multiple ASDs using the standard ASO.…”

Section: Discussionmentioning

confidence: 99%

Use of cribriform amplatzer septal occluder in the pediatric population

Pradhan

Jain

Sen

et al. 2021

Annals of Pediatric Cardiology

View full text Add to dashboard Cite

Purpose : Fenestrated atrial septal defects (F-ASDs) in the pediatric population pose a challenge for transcatheter device closure since multiple devices are not preferred in small hearts. Oversizing the Amplatzer Septal Occluder (ASO) to cover the surrounding fenestrations usually distorts the central waist as well as the disc profile and often defeats the purpose. This is a retrospective observational study with an aim to assess the feasibility and safety of cribriform ASO in closing F-ASDs in small children. Methods: Sixteen children with F-ASD who underwent device closure with cribriform ASO were included in the study. The fenestrated septal length (FSL) and the total septal length (TSL) were measured on transesophageal echocardiogram. A device size which was 1.5–2 times the FSL but smaller than the TSL was selected. The defect was closed with a device passed through a relatively centrally placed smaller fenestration. Results: The median age of the cohort was 5 years (2.5–10.5). Majority (14/16) required 25 or 30 mm cribriform ASO. Aneurysmal interatrial septum was seen in most of our patients (11/15). All the patients had successful device implantation. Complete closure of the defect was seen in 11 patients while 5 patients had insignificant residual shunt at a median follow-up of 40 months (1–60 months). There were no other complications. Conclusions: Cribriform ASO can be used safely and effectively in closing F-ASDs in children. Deployment of the device through a small central hole allows covering maximum fenestrations and gives more stability to the device. Residual shunts, although not infrequent, are insignificant.

show abstract

“…Hemodynamic changes do not often occur when there is a small residual shunt that cannot be resolved by other treatments. Regular follow-up after discharge is often sufficient for these patients [13]. …”

Section: Discussionmentioning

confidence: 99%

Feasibility, Safety and Long-Term Follow-Up of Transcatheter Closure of Secundum Atrial Septal Defects with Deficient Rims

Cao

Wang²,

Huang³

et al. 2016

Cardiology

View full text Add to dashboard Cite

Objective: The aim of this work was to evaluate the feasibility and safety of transcatheter closure procedures for the treatment of atrial septal defects (ASDs) with insufficient rims. Methods: A total of 507 secondary ASDs were divided into two groups based on whether they had deficient rims or not (152 vs. 355 cases,respectively). Any complications, including residual shunt, heart arrhythmia, occluder translocation, etc., were followed up for 1-3 years. Results: There were no differences in gender, weight, exposure time, ECG states, pulmonary pressure, the intervention success rate, occurrence of residual shunt, the operation time and occurrence of residual shunt during follow-up between the two groups (p > 0.05). However, the occurrence of rhythm disorders was significantly different between the two groups; ASDs with deficient rims were at an elevated risk (p < 0.05). Specifically, there was a significantly higher incidence in the occurrence of arrhythmia in the deficient rims group at 24 h postoperation, but no differences in arrhythmia incidence at any of the other follow-up time points (1, 3, 6, 12 and 36 months; p > 0.05). Conclusions: Patients with deficient rims experience a high success rate of ASD intervention and low rate of complications when the procedures are performed by experienced operators.

show abstract

Fenestrated Atrial Septal Defect Percutaneously Occluded by a Single Device: Procedural and Financial Considerations

Cited by 10 publications

References 10 publications

Atrial septal defect device closure and concurrent atrio‐fascicular Mahaim ablation in adult patient with Ebstein's anomaly

Atrial septal defect device closure and concurrent atrio‐fascicular Mahaim ablation in adult patient with Ebstein's anomaly

Use of cribriform amplatzer septal occluder in the pediatric population

Feasibility, Safety and Long-Term Follow-Up of Transcatheter Closure of Secundum Atrial Septal Defects with Deficient Rims

Contact Info

Product

Resources

About